Research ArticleClinical Investigation
Sensitivity in Detecting Osseous Lesions Depends on Anatomic Localization: Planar Bone Scintigraphy Versus 18F PET
Holger Schirrmeister, Albrecht Guhlmann, Klaus Elsner, Jörg Kotzerke, Gerhard Glatting, Marion Rentschler, Bernd Neumaier, Harald Träger, Karin Nüssle and Sven N. Reske
Journal of Nuclear Medicine October 1999, 40 (10) 1623-1629;
Holger Schirrmeister
Albrecht Guhlmann
Klaus Elsner
Jörg Kotzerke
Gerhard Glatting
Marion Rentschler
Bernd Neumaier
Harald Träger
Karin Nüssle
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Sensitivity in Detecting Osseous Lesions Depends on Anatomic Localization: Planar Bone Scintigraphy Versus 18F PET
Holger Schirrmeister, Albrecht Guhlmann, Klaus Elsner, Jörg Kotzerke, Gerhard Glatting, Marion Rentschler, Bernd Neumaier, Harald Träger, Karin Nüssle, Sven N. Reske
Journal of Nuclear Medicine Oct 1999, 40 (10) 1623-1629;
Sensitivity in Detecting Osseous Lesions Depends on Anatomic Localization: Planar Bone Scintigraphy Versus 18F PET
Holger Schirrmeister, Albrecht Guhlmann, Klaus Elsner, Jörg Kotzerke, Gerhard Glatting, Marion Rentschler, Bernd Neumaier, Harald Träger, Karin Nüssle, Sven N. Reske
Journal of Nuclear Medicine Oct 1999, 40 (10) 1623-1629;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
- Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer
- David Versus the Goliaths for the Detection of Bone Metastases
- Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
- Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
- Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
- Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
- Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by 18F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
- Radiation Exposure Should Not Limit Bone Scintigraphy with 18F-NaF
- Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients
- Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
- Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies
- An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts, and Case Examples
- [18F]Fluorodeoxyglucose Positron Emission Tomography Is More Sensitive Than Skeletal Scintigraphy for Detecting Bone Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging
- The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
- Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities
- Bone Imaging in Metastatic Breast Cancer
- Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
- Malignant Involvement of the Spine: Assessment by 18F-FDG PET/CT
- PET in the follow-up of differentiated thyroid cancer
- PET Imaging of Osteosarcoma
- Imaging in lung cancer: positron emission tomography scan
- Combined 18F-FDG and 11C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer
- Prospective Evaluation of the Clinical Value of Planar Bone Scans, SPECT, and 18F-Labeled NaF PET in Newly Diagnosed Lung Cancer
- Assessment of Porcine Bone Metabolism by Dynamic [18F]Fluoride Ion PET: Correlation with Bone Histomorphometry
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- Is There a Role for FDG PET in the Diagnosis of Musculoskeletal Neoplasms?